Health-related quality of life as a primary endpoint for growth hormone therapy.
Sandberg
David E
DE
Department of Psychiatry and Pediatrics, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14222, USA. dsandber@buffalo.edu
D023381:Endpoint Determination; D006130:Growth Disorders / Q000188:drug therapy* / Q000209:etiology; D020249:Hormone Replacement Therapy; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D011788:Quality of Life; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D019382:Human Growth Hormone